相似文献
1
Are two better than one? Angiotensin-converting enzyme inhibitors plus angiotensin receptor blockers for reducing blood pressure and proteinuria in kidney disease.
Clin J Am Soc Nephrol. 2008 Jan;3 Suppl 1(Suppl 1):S17-23. doi: 10.2215/CJN.03270807.
2
Renal and cardiovascular effects of angiotensin-converting enzyme inhibitor plus angiotensin II receptor antagonist therapy in children with proteinuria.
Pediatrics. 2006 Sep;118(3):e833-8. doi: 10.1542/peds.2005-2053. Epub 2006 Aug 21.
3
Add-on angiotensin receptor blocker in patients who have proteinuric chronic kidney diseases and are treated with angiotensin-converting enzyme inhibitors.
Clin J Am Soc Nephrol. 2006 Jul;1(4):730-7. doi: 10.2215/CJN.01110905. Epub 2006 May 17.
4
Angiotensin receptor blocker reduces proteinuria independently of blood pressure in children already treated with Angiotensin-converting enzyme inhibitors.
Kidney Blood Press Res. 2009;32(6):440-4. doi: 10.1159/000266478. Epub 2009 Dec 17.
5
Dual blockade of the renin-angiotensin system compared with a 50% increase in the dose of angiotensin-converting enzyme inhibitor: effects on proteinuria and blood pressure.
Nephrol Dial Transplant. 2004 Sep;19(9):2272-4. doi: 10.1093/ndt/gfh384. Epub 2004 Jul 13.
6
[Antihypertensive drug therapy--combination of AT1-receptor blocker and betablocker].
Dtsch Med Wochenschr. 2010 May;135(3):98. doi: 10.1055/s-0029-1244825. Epub 2010 Jan 14.
7
Antiproteinuric response to dual blockade of the renin-angiotensin system in primary glomerulonephritis: meta-analysis and metaregression.
Am J Kidney Dis. 2008 Sep;52(3):475-85. doi: 10.1053/j.ajkd.2008.03.008. Epub 2008 May 12.
8
Diuretic uptitration with half dose combined ACEI + ARB better decreases proteinuria than combined ACEI + ARB uptitration.
Nephrol Dial Transplant. 2010 Jul;25(7):2218-24. doi: 10.1093/ndt/gfp776. Epub 2010 Jan 26.
9
Renin-angiotensin-aldosterone system blockade and renal protection: angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers?
Acta Diabetol. 2005 Apr;42 Suppl 1:S33-41. doi: 10.1007/s00592-005-0179-x.
10
Slowing nephropathy progression: focus on proteinuria reduction.
Clin J Am Soc Nephrol. 2008 Jan;3 Suppl 1(Suppl 1):S3-10. doi: 10.2215/CJN.03250807.
引用本文的文献
1
Response and survival of dogs with proteinuria (UPC > 2.0) treated with angiotensin converting enzyme inhibitors.
J Vet Intern Med. 2023 Nov-Dec;37(6):2188-2199. doi: 10.1111/jvim.16864. Epub 2023 Oct 10.
2
Treatment of proteinuria in dogs with telmisartan: A retrospective study.
J Vet Intern Med. 2021 Jul;35(4):1810-1818. doi: 10.1111/jvim.16146. Epub 2021 May 10.
3
Role of aliskiren in blood pressure control and renoprotection.
Int J Nephrol Renovasc Dis. 2011;4:41-8. doi: 10.2147/IJNRD.S6653. Epub 2011 Mar 22.
本文引用的文献
1
Combination therapy with an angiotensin receptor blocker and an ACE inhibitor in proteinuric renal disease: a systematic review of the efficacy and safety data.
Am J Kidney Dis. 2006 Jul;48(1):8-20. doi: 10.1053/j.ajkd.2006.04.077.
2
Targeting albumin excretion rate in the treatment of the hypertensive diabetic patient with renal disease.
J Am Soc Nephrol. 2005 Mar;16 Suppl 1:S42-7. doi: 10.1681/asn.2004110973.
3
Systematic review of combined angiotensin-converting enzyme inhibition and angiotensin receptor blockade in hypertension.
Hypertension. 2005 May;45(5):880-6. doi: 10.1161/01.HYP.0000161880.59963.da. Epub 2005 Apr 4.
4
Diuretic and enhanced sodium restriction results in improved antiproteinuric response to RAS blocking agents.
J Am Soc Nephrol. 2005 Feb;16(2):474-81. doi: 10.1681/ASN.2004060505. Epub 2004 Dec 22.
5
Dual blockade of the renin-angiotensin system versus maximal recommended dose of ACE inhibition in diabetic nephropathy.
Kidney Int. 2003 May;63(5):1874-80. doi: 10.1046/j.1523-1755.2003.00940.x.
6
Additive effect of ACE inhibition and angiotensin II receptor blockade in type I diabetic patients with diabetic nephropathy.
J Am Soc Nephrol. 2003 Apr;14(4):992-9. doi: 10.1097/01.asn.0000054495.96193.bf.
7
Effects of combined ACE inhibitor and angiotensin II antagonist treatment in human chronic nephropathies.
Kidney Int. 2003 Mar;63(3):1094-103. doi: 10.1046/j.1523-1755.2003.00832.x.
8
Combination treatment of angiotensin-II receptor blocker and angiotensin-converting-enzyme inhibitor in non-diabetic renal disease (COOPERATE): a randomised controlled trial.
Lancet. 2003 Jan 11;361(9352):117-24. doi: 10.1016/S0140-6736(03)12229-5.
9
Angiotensin II receptor blockade: is there truly a benefit of adding an ACE inhibitor?
Hypertension. 2003 Jan;41(1):31-6. doi: 10.1161/01.hyp.0000047512.58862.a9.
10
Dual renin-angiotensin system blockade at optimal doses for proteinuria.
Kidney Int. 2002 Sep;62(3):1020-5. doi: 10.1046/j.1523-1755.2002.00536.x.
Zotero 插件